63610 Federal Register / Vol. 76, No. 198 / Thursday, October 13, 2011 / Notices 

authorizations. Bones would be 

imported into the U.S. for analyses. No 

live animal takes are authorized and no 

incidental harassment of animals would 

occur. The permit is valid for five years 

from the date of issuance. 

In compliance with the National 

Environmental Policy Act of 1969 (42 

U.S.C. 4321 et seq.), a final 

determination has been made that the 

activity proposed is categorically 

excluded from the requirement to 

prepare an environmental assessment or 

environmental impact statement. 

As required by the ESA, issuance of 

this permit was based on a finding that 

such permit: (1) Was applied for in good 

faith; (2) will not operate to the 

disadvantage of such endangered 

species; and (3) is consistent with the 

purposes and policies set forth in 

section 2 of the ESA. 

Dated: October 7, 2011. 

P. Michael Payne, 

Chief, Permits, Conservation and Education 

Division, Office of Protected Resources, 

National Marine Fisheries Service. 

[FR Doc. 2011–26497 Filed 10–12–11; 8:45 am] 

BILLING CODE 3510–22–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Notice of Meeting of Chronic Hazard 

Advisory Panel on Phthalates and 

Phthalate Substitutes 

AGENCY: Consumer Product Safety 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Consumer Product 

Safety Commission (‘‘CPSC’’ or 

‘‘Commission’’) announces the sixth 

meeting of the Chronic Hazard Advisory 

Panel (CHAP) on phthalates and 

phthalate substitutes. The Commission 

appointed this CHAP to study the 

effects on children’s health of all 

phthalates and phthalate alternatives as 

used in children’s toys and child care 

articles, pursuant to section 108 of the 

Consumer Product Safety Improvement 

Act of 2008 (CPSIA) (Pub. L. 110–314). 

DATES: The meeting will be held on 

Wednesday, November 2 through 

Friday, November 4, 2011. The meeting 

will begin at approximately 9 a.m. each 

day. It will end at approximately 5 p.m. 

on Wednesday and Thursday, and at 

approximately 2 p.m. on Friday. 

ADDRESSES: The meeting will be held in 

the fourth floor hearing room at the 

Commission’s offices at 4330 East West 

Highway, Bethesda, MD. 

Registration and Webcast: Members of 

the public who wish to attend the 

meeting in person may register on the 

day of the meeting. This meeting will 

also be available live via webcast at: 

http://www.cpsc.gov/Webcast. 

Registration is not necessary to view the 

webcast. There will not be any 

opportunity for public participation at 

this meeting. 

FOR FURTHER INFORMATION CONTACT: 

Michael Babich, Directorate for Health 

Sciences, Consumer Product Safety 

Commission, Bethesda, MD 20814; 

telephone (301) 504–7253; e-mail 

mbabich@cpsc.gov. 

SUPPLEMENTARY INFORMATION: Section 

108 of the CPSIA permanently prohibits 

the sale of any ‘‘children’s toy or child 

care article’’ containing more than 0.1 

percent of each of three specified 

phthalates: di-(2-ethylhexyl) phthalate 

(DEHP), dibutyl phthalate (DBP), and 

benzyl butyl phthalate (BBP). Section 

108 also prohibits on an interim basis, 

the sale of any ‘‘children’s toy that can 

be placed in a child’s mouth’’ or ‘‘child 

care article’’ containing more than 0.1 

percent of each of three additional 

phthalates: diisononyl phthalate (DINP), 

diisodecyl phthalate (DIDP), and di-noctyl phthalate (DNOP). 

Moreover, section 108 of the CPSIA 

requires the Commission to convene a 

CHAP ‘‘to study the effects on children’s 

health of all phthalates and phthalate 

alternatives as used in children’s toys 

and child care articles.’’ The CPSIA 

requires the CHAP to complete an 

examination of the full range of 

phthalates that are used in products for 

children and: 

• Examine all of the potential health 

effects (including endocrine disrupting 

effects) of the full range of phthalates; 

• Consider the potential health effects 

of each of these phthalates, both in 

isolation, and in combination with other 

phthalates; 

• Examine the likely levels of 

children’s, pregnant women’s, and 

others’ exposure to phthalates, based 

upon a reasonable estimation of normal 

and foreseeable use and abuse of such 

products; 

• Consider the cumulative effect of 

total exposure to phthalates, from 

children’s products and from other 

sources, such as personal care products; 

• Review all relevant data, including 

the most recent, best available, peerreviewed, scientific studies of these 

phthalates and phthalate alternatives 

that employ objective data-collection 

practices or employ other objective 

methods; 

• Consider the health effects of 

phthalates, not only from ingestion, but 

also as a result of dermal, hand-tomouth, or other exposure; 

• Consider the level at which there is 

a reasonable certainty of no harm to 

children, pregnant women, or other 

susceptible individuals and their 

offspring, reviewing the best available 

science, and using sufficient safety 

factors to account for uncertainties 

regarding exposure and susceptibility of 

children, pregnant women, and other 

potentially susceptible individuals; and 

• Consider possible similar health 

effects of phthalate alternatives used in 

children’s toys and child care articles. 

The CPSIA contemplates completion 

of the CHAP’s examination within 18 

months of the panel’s appointment, 

followed by an additional 6 months to 

complete their final report. The CHAP’s 

final report is expected in April 2012. 

The CHAP must make 

recommendations to the Commission 

about which phthalates, or 

combinations of phthalates (in addition 

to those identified in section 108 of the 

CPSIA), or phthalate alternatives that 

the panel determines should be 

prohibited from use in children’s toys or 

child care articles or otherwise 

restricted. The Commission selected the 

CHAP members from scientists 

nominated by the National Academy of 

Sciences. See 15 U.S.C. 2077, 2030(b). 

The CHAP met previously in April, 

July, and December 2010, and in March 

and July 2011. The CHAP heard 

testimony from interested parties at the 

July meeting. The November meeting 

will include invited speakers on 

Wednesday morning, followed by a 

discussion of the CHAP’s progress on its 

report. There will not be any 

opportunity for public comment at the 

November 2011 meeting. 

Dated: October 7, 2011. 

Todd A. Stevenson, 

Secretary. 

[FR Doc. 2011–26450 Filed 10–12–11; 8:45 am] 

BILLING CODE 6355–01–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Sunshine Act Meeting Notice 

TIME AND DATE: Wednesday, October 19, 

2011, 9 a.m.—12 p.m. 

PLACE: Room 420, Bethesda Towers, 

4330 East West Highway, Bethesda, 

Maryland. 

STATUS: Commission Meeting—Open to 

the Public. 

Matters to be Considered 

Decisional Matters: 

(1) Testing & Certification/ 

Components Parts Final Rules; 

(2) Representative—Notice of 


sroberts on DSK5SPTVN1PROD with NOTICES